Market Closed -
Bombay S.E.
11:00:48 10/05/2024 BST
5-day change
1st Jan Change
2,376
INR
-1.42%
+6.39%
+13.98%
Sales 2024
42.09B
504M
40.21B
Sales 2025 *
47.29B
566M
45.18B
Capitalization
297B
3.55B
284B
Net income 2024
8.16B
97.72M
7.8B
Net income 2025 *
9.46B
113M
9.04B
EV / Sales 2024
6.67
x
Net cash position
2024
*
7.97B
95.44M
7.62B
Net cash position
2025
*
8.39B
100M
8.01B
EV / Sales 2025 *
6.1
x P/E ratio 2024
34.4
x
P/E ratio 2025 *
31.8
x
Employees
7,713
Yield 2024 *
0.85%
Yield 2025 *
0.76%
Free-Float
50.31%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
INDIA STOCKS-India's Nifty 50 slips from record high as IT stocks weigh
05-03
RE
Ajanta Pharma's Consolidated Profit Nearly Doubles in Fiscal Q4
05-02
MT
Ajanta Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
05-02
CI
Ajanta Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024
05-02
CI
Ajanta Pharma Limited announces an Equity Buyback for 1,028,881 shares, representing 0.82% for INR 2,850 million.
05-02
CI
Transcript : Ajanta Pharma Limited, Q4 2024 Earnings Call, May 02, 2024
05-02
Ajanta Pharma Limited authorizes a Buyback Plan.
05-01
CI
Ajanta Pharma Limited?s Board intends to launch an Equity Buyback on May 2, 2024.
04-25
CI
Ajanta Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit
02-02
MT
Transcript : Ajanta Pharma Limited, Q3 2024 Earnings Call, Jan 31, 2024
01-31
Ajanta Pharma Limited Approves Second Interim Dividend for the Year Fiscal Year 2024, Payable on or After 19th February 2024
01-31
CI
Ajanta Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
01-31
CI
Ajanta Pharma Board to Consider Second Interim Dividend for Fiscal 2024
01-25
MT
Ajanta Pharma Limited Provides Earnings Guidance for the Full Year of Fiscal 2024
31/10/23
CI
Transcript : Ajanta Pharma Limited, Q2 2024 Earnings Call, Oct 31, 2023
31/10/23
More news
1 day -1.42%
1 week +6.39%
Current month +7.12%
1 month +10.48%
3 months +9.86%
6 months +26.77%
Current year +13.98%
More quotes
Managers
Title Age Since
Chief Executive Officer
48
31/12/98
Chief Executive Officer
52
31/12/95
Director of Finance/CFO
59
22/04/98
Members of the board
Title Age Since
Chief Executive Officer
52
31/12/95
Chairman
77
30/12/79
Director/Board Member
78
19/10/08
More insiders
Date
Price
Change
Volume
10/05/24
2,376
-1.42%
11 315
09/05/24
2,410
+1.82%
5,116
08/05/24
2,367
-1.32%
11,304
07/05/24
2,399
-0.68%
17,241
06/05/24
2,415
+1.60%
9,833
Delayed Quote
Bombay S.E., May 10, 2024 at 11:00 am
More quotes
Ajanta Pharma Limited is an India-based specialty pharmaceutical company. The Company provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. The Company is engaged in the manufacturing and sale of branded generic and generic pharmaceutical products. It has a wide range of therapeutic segments, such as cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecology, pediatric and general health products. Its branded generics business is spread across India, the rest of Asia, and Africa. Its business also consists of two verticals: United States generics and institutional business in Africa. Its ophthalmology products include Bimat (anti glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic). The Company's cardiology products include MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex and Vilatin.
More about the company
Last Close Price
2,377
INR
Average target price
2,440
INR
Spread / Average Target
+2.64%
Consensus
1st Jan change
Capi.
+19.62% 42.97B +24.52% 22.49B +20.29% 14.93B +7.48% 13.14B +42.51% 11.67B -8.84% 6.86B -0.05% 6.79B -8.87% 5.73B +13.13% 5.54B
Generic Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1